Figure 4From: Systematic analysis of genome-wide fitness data in yeast reveals novel gene function and drug actionThe ability of co-inhibition to predict shared therapeutic use was higher for the homozygous than for the heterozygous dataset. As reference, we used a set of compound pairs with shared therapeutic use (WHO ATC level 3 code). As in Figure 3, we used only pairs of compounds that were tested in both the (a) heterozygous and (b) homozygous datasets.Back to article page